Lundbeck
HLUN-B.CO
$6.06
Share price
0.42%
Change (1 day)
-7.82%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
EPS for Lundbeck (HLUN-B.CO)
EPS in 2023 (TTM): $0.48
According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.49. In 2022 the company made an earnings per share (EPS) of $0.37 a decrease over its 2021 EPS that were of $0.84.
EPS history for Lundbeck from 2009 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $0.48 | 28.12% |
| 2022 | $0.37 | -55.47% |
| 2021 | $0.84 | -51.83% |
| 2020 | $1.74 | -28.01% |
| 2019 | $2.41 | -44.08% |
| 2018 | $4.32 | 51.94% |
| 2017 | $2.84 | 126.64% |
| 2016 | $1.25 | -120.84% |
| 2015 | -$6.01 | 5622.18% |
| 2014 | -$0.11 | -110.03% |
| 2013 | $1.05 | -28.08% |
| 2012 | $1.46 | -52.1% |
| 2011 | $3.04 | -1.31% |
| 2010 | $3.08 | 15.61% |
| 2009 | $2.67 |